Gossamer Bio (GOSS) Operating Income (2022 - 2025)
Historic Operating Income for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$49.1 million.
- Gossamer Bio's Operating Income fell 4479.79% to -$49.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$160.8 million, marking a year-over-year decrease of 12084.79%. This contributed to the annual value of -$59.9 million for FY2024, which is 6739.26% up from last year.
- Latest data reveals that Gossamer Bio reported Operating Income of -$49.1 million as of Q3 2025, which was down 4479.79% from -$38.8 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Operating Income registered a high of $52.1 million during Q2 2024, and its lowest value of -$56.0 million during Q3 2022.
- In the last 4 years, Gossamer Bio's Operating Income had a median value of -$46.3 million in 2023 and averaged -$39.1 million.
- As far as peak fluctuations go, Gossamer Bio's Operating Income surged by 21249.89% in 2024, and later crashed by 17442.36% in 2025.
- Quarter analysis of 4 years shows Gossamer Bio's Operating Income stood at -$54.4 million in 2022, then rose by 9.81% to -$49.0 million in 2023, then increased by 26.31% to -$36.1 million in 2024, then plummeted by 35.94% to -$49.1 million in 2025.
- Its Operating Income was -$49.1 million in Q3 2025, compared to -$38.8 million in Q2 2025 and -$36.8 million in Q1 2025.